Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.

Fabris E, Ottervanger JP, Hermanides RS, Ten Berg JM, Sinagra G, Koopmans PC, Giannitsis E, Hamm C, van 't Hof AWJ.

Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043. [Epub ahead of print]

PMID:
30585388
2.

Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.

Kalkman DN, Kerkmeijer LS, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2018 Dec 18. doi: 10.1002/ccd.28047. [Epub ahead of print]

PMID:
30565371
3.

Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.

van Dongen DN, Tolsma RT, Fokkert MJ, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AW, Ottervanger JP.

Eur Heart J Acute Cardiovasc Care. 2018 Nov 23:2048872618813846. doi: 10.1177/2048872618813846. [Epub ahead of print]

PMID:
30468395
4.

Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome.

van Dongen DN, Fokkert MJ, Tolsma RT, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AWJ, Ottervanger JP.

Am J Cardiol. 2018 Nov 15;122(10):1610-1616. doi: 10.1016/j.amjcard.2018.07.037. Epub 2018 Aug 20.

PMID:
30262402
5.

Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Tavenier AH, Hermanides RS, Ottervanger JP, Ter Horst PGJ, Kedhi E, van 't Hof AWJ.

Drug Saf. 2018 Dec;41(12):1303-1308. doi: 10.1007/s40264-018-0710-y. Review.

PMID:
30155802
6.

Trends in Cardiovascular and Bleeding Outcomes in Acute Coronary Syndrome Patients Treated With or Without Proton Pump Inhibitors During the Introduction of Novel P2Y12 Inhibitors: a Five-Year Experience From a Single-Centre Observational Registry.

Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van 't Hof AWJ.

Eur Heart J Cardiovasc Pharmacother. 2018 Aug 2. doi: 10.1093/ehjcvp/pvy030. [Epub ahead of print]

PMID:
30084902
7.

2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group.

Arslan F, Bongartz L, Ten Berg JM, Jukema JW, Appelman Y, Liem AH, de Winter RJ, van 't Hof AWJ, Damman P.

Neth Heart J. 2018 Sep;26(9):417-421. doi: 10.1007/s12471-018-1134-0.

8.

Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Collet JP, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm CW, Van 't Hof AW, Montalescot G; ATLANTIC Investigators.

EuroIntervention. 2018 Sep 20;14(7):789-797. doi: 10.4244/EIJ-D-18-00182.

9.

Impact of a Graded Exercise Program on V˙O2peak and Survival in Heart Failure Patients.

Snoek JA, Eijsvogels TMH, VAN 't Hof AWJ, Prescott E, Hopman MT, Kolkman E, DE Kluiver EDP.

Med Sci Sports Exerc. 2018 Nov;50(11):2185-2191. doi: 10.1249/MSS.0000000000001688.

PMID:
29933343
10.

Optimal pharmacological therapy in ST-elevation myocardial infarction-a review : A review of antithrombotic therapies in STEMI.

Hermanides RS, Kilic S, van 't Hof AWJ.

Neth Heart J. 2018 Jun;26(6):296-310. doi: 10.1007/s12471-018-1112-6. Review.

11.

Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).

Badings EA, Hermanides RS, The SHK, Dambrink JE, Rasoul S, Van Wijngaarden J, Van 't Riet E, Kolkman E, Remkes WS, Tjeerdsma G, Van Der Wielen MLJ, Lok DJA, Suryapranata H, Van 't Hof AWJ.

Am J Cardiol. 2018 May 15;121(10):1123-1128. doi: 10.1016/j.amjcard.2018.01.031. Epub 2018 Feb 21.

PMID:
29606324
12.

Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting.

Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van 't Hof AWJ.

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):102-110. doi: 10.1093/ehjcvp/pvy005.

PMID:
29394340
13.

Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty.

Roolvink V, Hemradj VV, Ottervanger JP, van 't Hof AW, Dambrink JE, Gosselink AM, Kedhi E, Suryapranata H; Zwolle Myocardial Infarction Study Group.

Eur Heart J Acute Cardiovasc Care. 2018 Jan 1:2048872617754277. doi: 10.1177/2048872617754277. [Epub ahead of print]

PMID:
29376399
14.

[Should we follow the HEART score in patients presenting with chest pain?]

Damman P, van 't Hof AW.

Ned Tijdschr Geneeskd. 2017;161:D1945. Dutch.

PMID:
29057730
15.

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience.

Remkes WS, Hermanides RS, Kennedy MW, Fabris E, Kaplan E, Ottervanger JP, van 't Hof AWJ, Kedhi E.

Neth Heart J. 2017 Nov;25(11):611-617. doi: 10.1007/s12471-017-1038-4.

16.

A Protocol for Diagnosis and Management of Aortic Atherosclerosis in Cardiac Surgery Patients.

Jansen Klomp WW, Brandon Bravo Bruinsma GJ, Van 't Hof AWJ, Grandjean JG, Nierich AP.

Int J Vasc Med. 2017;2017:1874395. doi: 10.1155/2017/1874395. Epub 2017 Aug 9. Review.

17.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome : Practical lessons from a review.

Ten Berg JM, Zwart B, van 't Hof AWJ, Liem A, Waltenberger J, de Winter RJ, Jukema JW.

Neth Heart J. 2017 Dec;25(12):655-663. doi: 10.1007/s12471-017-1023-y. Review.

18.

Aortic dissection, a diagnostic challenge.

Jansen Klomp WW, Nierich AP, van 't Hof AWJ.

Neth Heart J. 2017 Sep;25(9):531-532. doi: 10.1007/s12471-017-1026-8. No abstract available.

19.

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome.

Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides RS, Van Wijngaarden J, Suryapranata H, van 't Hof AW.

Open Heart. 2017 Mar 2;4(1):e000538. doi: 10.1136/openhrt-2016-000538. eCollection 2017.

20.

Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome.

Hoedemaker NP, Ten Haaf ME, Maas JC, Damman P, Appelman Y, Tijssen JG, de Winter RJ, van 't Hof AW.

Neth Heart J. 2017 Apr;25(4):264-270. doi: 10.1007/s12471-017-0947-6.

Supplemental Content

Loading ...
Support Center